Comparison of Therapeutic Efficacy of Intravitreal Bevacizumab plus Macular Laser versus Intravitreal Triamcinolone Acetonide plus Macular Laser in Primary Treatment of Diabetic Macular Edema
Journal Title: Scholars Journal of Applied Medical Sciences - Year 2017, Vol 5, Issue 8
Abstract
Abstract:To compare the efficacy of intravitreal bevacizumab and macular laser vis-a-vis intravitreal triamcinolone acetonide and macular laser in primary treatment for diabetic macular edema. Randomised, prospective, comparative two-arm, non-interventional study with five time points. 60 eyes of 30 patients with bilateral DME and no previous ocular intervention participated in the study and were randomised into two groups. Both eyes of Group A patients received an intravitreal injection of 1.25mg of Bevacizumab and Group B patients received 4mg of Triamcinolone acetonide. One week after injection, all patients underwent macular photocoagulation. The clinical course of best corrected visual acuity (BCVA) in decimal fraction system and average central retinal thickness (CRT) using optical coherence tomography was monitored for up to 12 weeks after the injection. Before injection, mean of CRT and BCVA were 411.37±165.71µ and 0.252±0.154 in Bevacizumab group (A) and 356.50 ± 152.26µ and 0.378 ±0.248 in Triamcinolone group (B). Two weeks after injection and one week after macular photocoagulation (MPC), both groups showed significant regression of macular edema and improvement in vision. Bevacizumab group showed better results at 2weeks.The difference in CRT and BCVA at 2 weeks from baseline were 84.40 ± 22.68µ (p= .008) & 0.111 ± 0.015 (p< .001) in group A and 52.30± 15.63µ (p= .023) & 0.089± 0.033 (p= .113) in group B. The efficacy of Triamcinolone improved 4th week onwards, became comparable to Bevacizumab group at 8th week. At 12 weeks, the Triamcinolone group achieved slightly better results than Bevacizumab group, which started showing recurrence of macular edema. The differences in CRT at baseline and at 12 weeks in group A and group B respectively are 102.47 ± 23.50 µ(p= .001) and 108 ± 21.60 µ(p< .001).The differences in between baseline and BCVA at 12weeks in group A and group B respectively are 0.210± 0.026 and 0.214±0.04. Within the study period and with the generally used concentration, intravitreal bevacizumab, as treatment modality brings earlier reduction in DME, but at 4 and 8 weeks, the efficacy in terms of p- value in between two groups is similar. At 12 weeks bevacizumab group starts showing the beginning of waning effect of drug, although still comparable to Triamcinolone group. No increase in IOP was seen in bevacizumab group while one eye developed raised IOP in Triamcinolone group. Keywords:Intravitreal injections, Bevacizumab (Avastin), Triamcinolone Acetonide, Macular Laser Photocoagulation, Diabetic Macular Edema
Authors and Affiliations
Kanika Sharma
Keywords
Related Articles
- EP ID EP373173
- DOI -
- Views 22
- Downloads 0
To Study the Rifampicin Resistance in Sputum Positive Pulmonary Tuberculosis Patient by CB-NAAT
Tuberculosis (TB) burden in India is very high accounting for nearly 20% of the global incidence. India also ranks second in holding multi drug resistant (MDR)-TB cases. To identify rifampicin resistance cases in sputum...
A Study of Socio Demographic Profile of Geriatric Population in the Field Practice Area of a Medical College
Population based data on socio-demographic status and various social-economic circumstances are imperative for public health intervention with geriatric population. This study is undertaken to study the socio-demographic...
Assessment of radiation protection (Knowledge and performance) practices among radiographers in Taif Hospitals Saudi Arabia
Abstract: Radiation protection is very important issue. This study aimed to evaluate and asses the knowledge and performance of radiation protection during hospital practice among the radiology staff in radiology departm...
Clinico-Laboratory Profile of Severe Pediatric Scrub Typhus
Scrub typhus is a mite-borne bacterial infection of humans caused by Orientia tsutsugamushi that causes a generalized vasculitis that may involve the tissues of any organ system. It is a re-emerging disease affecting man...
Influence of menstrual cycle phases on serum levels of lipids and lipoprotein ratios in eumenorrheic women
Abstract: It is believed that the cyclic variations in sex hormones across the menstrual cycle may have effects on the lipid profile and hence on cardiovascular health. Thus, the purpose of study was to find out the seru...